Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies

Area of Science:

• Oncology
• Gastroenterology
• Endocrinology

Background:

• Neuroendocrine tumors (NETs) are rare neoplasms originating primarily in the gastrointestinal tract and lungs.
• NET incidence is increasing, with many patients diagnosed with advanced disease or experiencing post-surgical relapse.
• Significant unmet needs exist for effective therapies in advanced-stage NETs.

Purpose of the Study:

• To review current therapeutic strategies for pancreatic and non-pancreatic gastrointestinal neuroendocrine tumors.
• To discuss recent advancements in NET management, focusing on targeted therapy approaches.
• To address the need for improved treatment options for advanced NETs.

Main Methods:

• Literature review of current and emerging therapies for neuroendocrine tumors.
• Analysis of treatment outcomes and efficacy of targeted therapies.
• Synthesis of information on pancreatic and gastrointestinal NET management.

Main Results:

• Current therapies for NETs vary based on tumor origin and stage.
• Targeted therapies represent a significant area of advancement in NET management.
• The review synthesizes existing knowledge and highlights future directions.

Conclusions:

• Improved therapeutic interventions are crucial for managing advanced neuroendocrine tumors.
• Targeted therapy offers promising avenues for enhancing NET treatment efficacy.
• Continued research is essential to address the rising incidence and challenges in NET care.